send to a friend by email
2026-02-11
According to the financial statements for JERUSALEM PHARMACEUTICALS of 31/12/2025 Net profit after tax reached 10,306,179 USD , compared with Net profit after tax of 5,061,833 USD of year 2024 a net increase of 103.61% . and Total assets reached 112,463,257 USD , compared with Total assets of 89,154,171 USD at the end of year 2024 a net increase of 26.14% . and Total Liabilities reached 24,260,909 USD , compared with Total Liabilities of 17,547,164 USD at the end of year 2024 a net increase of 38.26% . and Total Owners' Equity reached 88,202,348 USD Including None-Controlling Interests of 1,083,488 USD, compared with Total Owners' Equity of 71,607,007 USD Including None-Controlling Interests of 1,010,817 USD at the end of year 2024 a net increase of 23.18% .
|